Marcus Schulz - 03 Aug 2022 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Aug 2022, 20:00:45 UTC
Prior SEC filing
26 Jul 2022
Next SEC filing
11 Aug 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marcus Schulz

Key filing fact

Marcus Schulz filed Form 4 for BIOLIFE SOLUTIONS INC (BLFS) on 05 Aug 2022.

Key facts

  • This page summarizes Marcus Schulz's Form 4 filing for BIOLIFE SOLUTIONS INC (BLFS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 05 Aug 2022, 20:00.

Change

  • Previous filing in this sequence was filed on 26 Jul 2022.
  • Current net transaction value: -$92,138.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BLFS transaction

Common Stock

Sale

Transaction value
$92,138
Shares
-4,600
Change %
-11%
Price
$20.03
Shares after
36,218
Date
03 Aug 2022
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of June 14, 2022.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.01 to $20.06, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .